ABSTRACT
Recent genome-wide association studies (GWASs) of several individual sleep traits have identified hundreds of genetic loci, suggesting diverse mechanisms. Moreover, sleep traits are moderately correlated, and together may provide a more complete picture of sleep health, while also illuminating distinct domains. Here we construct novel sleep health scores (SHSs) incorporating five core self-report measures: sleep duration, insomnia symptoms, chronotype, snoring, and daytime sleepiness, using additive (SHS-ADD) and five principal components-based (SHS-PCs) approaches. GWASs of these six SHSs identify 28 significant novel loci adjusting for multiple testing on six traits (p<8.3e-9), along with 341 previously reported loci (p<5e-08). The heritability of the first three SHS-PCs equals or exceeds that of SHS-ADD (SNP-h2=0.094), while revealing sleep-domain-specific genetic discoveries. Significant loci enrich in multiple brain tissues and in metabolic and neuronal pathways. Post GWAS analyses uncover novel genetic mechanisms underlying sleep health and reveal connections to behavioral, psychological, and cardiometabolic traits.
Competing Interest Statement
Andrew J. K. Phillips has received research funding from Versalux and Delos, and he is co-founder and co-director of Circadian Health Innovations PTY LTD. Susan Redline received consulting fees from Jazz Pharma, Eli Lilly, and ApniMed Inc. Martin Rutter has received consulting fees from Eli Lilly.
Funding Statement
This work was supported by the National Institute of Health (NIH) grants R01HL153814 (to H.W.), R01HL146751 (to R.S.), R35HL135818 (to S.R.), and NIHR Manchester Biomedical Research Centre. S.D.K. is supported by the National Institute of Health and Care Research (NIHR) Oxford Health Biomedical Research Centre, NIHR Efficacy and Mechanisms Evaluation Programme (Ref: 131789), NIHR Programme Grants for Applied Research (Ref: 203667) and the Wellcome Trust (226784/Z/22/Z and 227093/Z/23/Z). D.A.L. is supported by the UK Medical Research Council (MC_UU_00032/05), British Heart Foundation (CH/F/20/90003 and AA/18/1/34219) and Diabetes UK (17/0005700). J.I.R. is supported by the National Center for Advancing Translational Sciences, CTSI grant UL1TR001881, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The Hispanic Community Health Study/Study of Latinos was supported by contracts from the National Heart Lung and Blood Institute to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), the University of Illinois at Chicago (HHSN268201300003I), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following Institutes/Centers/Offices contributed to the HCHS/SOL through a transfer of funds to the National Heart Lung and Blood Institute: National Center on Minority Health and Health Disparities, the National Institute of Deafness and Other Communications Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurologic Disorders and Stroke, and the Office of Dietary Supplements.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Anonymized data and materials have been made publicly available at the UK Biobank Access Management System and can be accessed at https://bbams.ndph.ox.ac.uk/ams/.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
